Literature DB >> 9163392

Ocular dominance in human V1 demonstrated by functional magnetic resonance imaging.

R S Menon1, S Ogawa, J P Strupp, K Uğurbil.   

Abstract

Very high resolution functional magnetic resonance imaging (fMRI) at a 4 Tesla (T) magnetic field was used to map ocular dominance regions in the human visual cortical layers using the blood oxygen level dependent (BOLD) contrast mechanism. The fMRI response from primary visual cortex (V1) exhibited a distribution of ocular dominance reminiscent of the single-cell recordings of Hubel and Wiesel. Pixels could be grouped into seven categories varying from left-only response to binocular-only response to right-only responses. Nonspecific responses were found in the MRI-visible draining veins as well as in the parenchyma. Although large vessel BOLD signals are easily detectable, regardless of field strength, they demonstrate a fMRI response to photic input that could not be used to distinguish ocular dominance. The difference in BOLD response between a region activated by one eye and that activated by the other is only 2.9% on average. This necessitates the use of a difference paradigm to visualize the regions of ocular dominance accurately. The data show that BOLD-based fMRI is sensitive to neuronal activity in cortical columns when using differential techniques, opening up the possibility of mapping specialized populations of neurons in humans that are not accessible to electrophysiological or other methods of invasive mapping.

Entities:  

Mesh:

Year:  1997        PMID: 9163392     DOI: 10.1152/jn.1997.77.5.2780

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  78 in total

Review 1.  Functional mapping in the human brain using high magnetic fields.

Authors:  K Uğurbil; X Hu; W Chen; X H Zhu; S G Kim; A Georgopoulos
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-07-29       Impact factor: 6.237

2.  New insights into the hemodynamic blood oxygenation level-dependent response through combination of functional magnetic resonance imaging and optical recording in gerbil barrel cortex.

Authors:  A Hess; D Stiller; T Kaulisch; P Heil; H Scheich
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

3.  A new approach to measure single-event related brain activity using real-time fMRI: feasibility of sensory, motor, and higher cognitive tasks.

Authors:  S Posse; F Binkofski; F Schneider; D Gembris; W Frings; U Habel; J B Salloum; K Mathiak; S Wiese; V Kiselev; T Graf; B Elghahwagi; M L Grosse-Ruyken; T Eickermann
Journal:  Hum Brain Mapp       Date:  2001-01       Impact factor: 5.038

4.  Localized cerebral blood flow response at submillimeter columnar resolution.

Authors:  T Q Duong; D S Kim; K Uğurbil; S G Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

5.  The cortical representation of the hand in macaque and human area S-I: high resolution optical imaging.

Authors:  D Shoham; A Grinvald
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

6.  Columnar specificity of microvascular oxygenation and blood flow response in primary visual cortex: evaluation by local field potential and spiking activity.

Authors:  Zheng Wang; Anna W Roe
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-26       Impact factor: 6.200

Review 7.  Magnetic resonance imaging at ultrahigh fields.

Authors:  Kamil Ugurbil
Journal:  IEEE Trans Biomed Eng       Date:  2014-03-25       Impact factor: 4.538

Review 8.  The rapid development of high speed, resolution and precision in fMRI.

Authors:  David A Feinberg; Essa Yacoub
Journal:  Neuroimage       Date:  2012-01-14       Impact factor: 6.556

Review 9.  New developments in magnetic resonance imaging of the brain.

Authors:  Alan P Koretsky
Journal:  NeuroRx       Date:  2004-01

10.  Eye preference within the context of binocular functions.

Authors:  Walter H Ehrenstein; Birgit E Arnold-Schulz-Gahmen; Wolfgang Jaschinski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.